miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met.
about
Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players?c-Met as a Target for Personalized TherapyAnti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target moleculeMicroRNAs as potential signatures of environmental exposure or effect: a systematic reviewHepatitis B virus promotes cancer cell migration by downregulating miR-340-5p expression to induce STAT3 overexpression.MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.B-cell lymphoma 6 protein stimulates oncogenicity of human breast cancer cellsmiR-320a is an independent prognostic biomarker for invasive breast cancerMicroRNA 340 is involved in UVB-induced dendrite formation through the regulation of RhoA expression in melanocytes.Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion.Identification of microRNA-regulated gene networks by expression analysis of target genes.MicroRNA-340 as a modulator of RAS-RAF-MAPK signaling in melanoma.Prognostic significance of the expression of GFRα1, GFRα3 and syndecan-3, proteins binding ARTEMIN, in mammary carcinoma.miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1.miR-340 suppresses glioblastoma multiformeSjCa8, a calcium-binding protein from Schistosoma japonicum, inhibits cell migration and suppresses nitric oxide release of RAW264.7 macrophages.Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs.MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.Modulation of cancer traits by tumor suppressor microRNAs.Prolactin Inhibits BCL6 Expression in Breast Cancer Cells through a MicroRNA-339-5p-Dependent PathwayMicroRNA-340 Inhibits Tumor Cell Proliferation and Induces Apoptosis in Endometrial Carcinoma Cell Line RL 95-2.Expression of microRNA-370 in human breast cancer compare with normal samples.miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRASmiR-340 and ZEB1 negative feedback loop regulates TGF-β- mediated breast cancer progressionPancreatic cancer diagnosis by free and exosomal miRNA.miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions.MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-MetCombined microRNA-340 and ROCK1 mRNA profiling predicts tumor progression and prognosis in pediatric osteosarcoma.MicroRNA-10a is down-regulated by DNA methylation and functions as a tumor suppressor in gastric cancer cellsRole of microRNA-mediated MMP regulation in the treatment and diagnosis of malignant tumors.Deregulated microRNAs in CD4+ T cells from individuals with latent tuberculosis versus active tuberculosis.XIAP 3'-untranslated region as a ceRNA promotes FSCN1 function in inducing the progression of breast cancer by binding endogenous miR-29a-5p.EphB3-targeted regulation of miR-149 in the migration and invasion of human colonic carcinoma HCT116 and SW620 cells.MET: a promising anticancer therapeutic target.MicroRNAs as therapeutic targets and their potential applications in cancer therapy.miRNAs regulate expression and function of extracellular matrix molecules.While at Rome miRNA and TRAIL do whatever BCR-ABL commands to do.microRNAs: a new class of breast cancer biomarkers.MicroRNAs in the Regulation of MMPs and Metastasis.Illustrating the interplay between the extracellular matrix and microRNAs.
P2860
Q26772219-66FC8C6B-4B50-4381-9D9C-ACF7468FE57FQ26775483-DC667435-51F3-437E-9E6C-B99429DA75ABQ27015933-A461B4F1-EDC9-4B93-A900-F3ABC669A9FAQ28393390-47EB6239-BD5F-4B8B-8796-EDDE5A4AB797Q33556596-620C0210-233B-48A5-8908-13653EAA2194Q33560283-B21BFF17-7641-4ED6-9F0D-4B0180C3F9E3Q33786387-CD12F29A-2DE7-4A12-BD01-D93B9D0668CAQ33967807-AFDC2507-3304-4167-911E-869848DB6093Q34056592-30440C63-0032-4D46-BFD1-9CBA37BF99FFQ34146970-BE7AB46D-3DE5-441D-8748-63744BB3E15FQ34255426-7CE7FC8B-0A7F-42DC-9DAE-B7F7745394FBQ34459150-3D4353BC-35F4-4860-ADD4-0BDB51D41F7DQ34564120-7F5425B9-A681-4CFE-9A2B-0DD397466894Q35475274-1CCEB63F-A36A-48F6-8E1C-75801627DBD2Q35832337-071557D6-7613-4D87-AF60-0A80DA51D909Q36135568-68E4B418-4A42-4B41-925D-EAEE83EA5C2DQ36335774-490A324B-B233-4435-92F4-366A09FDAA5EQ36428863-468AF36A-3A6D-4ED8-9DA0-52ADADFDB0C4Q36590130-9ED64A58-CFFE-4B03-9338-9444A7DFEDA1Q36768980-28BB4D18-19D8-4CFD-BD3D-2E2BD3C94542Q37029456-8B01394C-0351-456E-923B-351471254455Q37157812-5152272B-5671-4773-B249-39826711CCD9Q37190094-85018BFB-A878-4534-9ACE-844F521148B6Q37295569-51B8BDA3-FFDD-4F79-9CA8-1DDB62C21CB6Q37382231-4D9BAB09-4267-4F08-B18C-5E88725C528DQ37439422-F8ECD129-EC06-4D65-8C42-93B4717A9828Q37462436-BCF0E193-8507-4D06-8B81-067B7ED2BF5BQ37535484-AE772696-DF9D-445C-A685-FD5162636BD0Q37539416-8B3E9407-8E66-456F-8884-52AB7A103CC6Q37540188-132C8ACD-65C2-479B-81A2-40F307B0827EQ37638914-B90ECC9D-8FB7-4A31-96A8-42CF9E3D96A0Q37725519-02546332-2BB1-4266-995C-69E2DA6352C9Q37735622-E7396F41-028D-4871-B75C-69784DB37E8EQ38008247-7EA7A77E-E122-4808-B89D-94FA2D642EF7Q38018097-494F63DF-0474-4B13-9C7A-19D89C3A1B6DQ38060445-35143612-AC40-408A-A46F-48B1DD961815Q38066406-C3D0D5E8-95ED-419C-B783-0C8DEB65871BQ38197675-D303DB5C-AA26-4854-8A98-10E0A458F2B4Q38199556-2F0E976D-63D9-44E1-9229-DA868A3921AAQ38206794-E5282666-AC69-4B01-8B30-3D3CF3E59C93
P2860
miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
miR-340 inhibition of breast c ...... argeting of oncoprotein c-Met.
@ast
miR-340 inhibition of breast c ...... argeting of oncoprotein c-Met.
@en
miR-340 inhibition of breast c ...... argeting of oncoprotein c-Met.
@nl
type
label
miR-340 inhibition of breast c ...... argeting of oncoprotein c-Met.
@ast
miR-340 inhibition of breast c ...... argeting of oncoprotein c-Met.
@en
miR-340 inhibition of breast c ...... argeting of oncoprotein c-Met.
@nl
prefLabel
miR-340 inhibition of breast c ...... argeting of oncoprotein c-Met.
@ast
miR-340 inhibition of breast c ...... argeting of oncoprotein c-Met.
@en
miR-340 inhibition of breast c ...... argeting of oncoprotein c-Met.
@nl
P2093
P2860
P356
P1433
P1476
miR-340 inhibition of breast c ...... argeting of oncoprotein c-Met.
@en
P2093
Chao-qun Wang
Gui-hong Zhang
Jing Huang
Jing-jing Zhao
Nong Zhang
Shan-shan Mao
Xiao-chun Xu
Xiao-nan Wang
Zheng-sheng Wu
P2860
P304
P356
10.1002/CNCR.25860
P407
P577
2011-01-10T00:00:00Z